STOCK TITAN

TAKEDA PHARM CO LTD (TKPHF) Debt by Year

TKPHF

TAKEDA PHARM CO LTD carried $26.5B in long-term debt against $2.6B in cash and equivalents at the end of fiscal year 2025. Long-term debt fell 10.6% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters TAKEDA PHARM CO LTD has filed alongside them.

FY2025 annual
Long-Term Debt $26.5B
Cash & Equivalents $2.6B
YoY -10.6%
5Y CAGR -8.8%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TKPHF Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-F
Long-Term Debt$26.5B-10.6%$29.6B-2.8%$30.5B-10.7%$34.1B-18.2%$41.7B-0.5%$41.9B-2.7%$43.1B+364.0%$9.3BN/A
Cash & Equivalents$2.6B-15.1%$3.0B-24.7%$4.0B-42.6%$7.0B-19.9%$8.7B+47.3%$5.9B-6.5%$6.3B+128.7%$2.8B-3.3%$2.9B

TKPHF Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
Long-Term Debt$26.5B-10.6%$29.6B-2.8%$30.5B-10.7%$34.1B-18.2%$41.7B-0.5%$41.9B-2.7%$43.1B+364.0%$9.3B
Cash & Equivalents$2.6B-15.1%$3.0B-24.7%$4.0B-42.6%$7.0B-19.9%$8.7B+47.3%$5.9B-6.5%$6.3B+128.7%$2.8B

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More TAKEDA PHARM CO LTD financials

Frequently Asked Questions

What was TAKEDA PHARM CO LTD's long-term debt in fiscal year 2025?

TAKEDA PHARM CO LTD carried $26.5B in long-term debt against $2.6B in cash and equivalents at the end of fiscal year 2025.

How fast is TAKEDA PHARM CO LTD's long-term debt growing?

TAKEDA PHARM CO LTD (TKPHF) long-term debt fell by 10.6% year over year, from $29.6B to $26.5B in fiscal year 2025.

What was TAKEDA PHARM CO LTD's long-term debt in the most recent quarter?

TAKEDA PHARM CO LTD (TKPHF) reported $26.5B in long-term debt in Q4 2025. This represents a decrease of 10.6% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what TAKEDA PHARM CO LTD (TKPHF) reported on that line in every period on record.